Characterization of metal-ion-nucleotide based particulate matter in solutions of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA)

The antiviral drug 9-[2-(phosphonomethoxy)ethyl]adenine, PMEA, was developed as an intravenous product for the treatment of human immunodeficiency virus infection. During the course of stability monitoring, PMEA i.v. injection was found to undergo particulate matter formation under extended storage...

Full description

Saved in:

Bibliographic Details
Published in:	PDA journal of pharmaceutical science and technology Vol. 51; no. 1; p. 30
Main Authors:	Yuan, L C, Visor, G C
Format:	Journal Article
Language:	English
Published:	United States 01-01-1997
Subjects:	Adenine - analogs & derivatives Adenine - chemistry Antiviral Agents - chemistry Drug Stability Iron - analysis Organophosphonates Solutions Zinc - analysis
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The antiviral drug 9-[2-(phosphonomethoxy)ethyl]adenine, PMEA, was developed as an intravenous product for the treatment of human immunodeficiency virus infection. During the course of stability monitoring, PMEA i.v. injection was found to undergo particulate matter formation under extended storage at ambient temperature. Isolation and characterization of the particulates revealed them to be metal ion-PMEA complexes. The principle metal ions associated with the particulates were iron and zinc, present as trace impurities (< or = 40 ppm) in PMEA drug substance determined by inductively coupled argon plasma spectroscopy. These visible particles are characterized by energy-dispersive x-ray spectrometry and fourier transform infrared spectroscopy. This study describes the systematic evaluation of the observed solution phenomena and details alternative formulation systems to eliminate particulate formation in the PMEA injectable product.
ISSN:	1079-7440